-
Reslizumab, sold
under the
brand names Cinqair and Cinqaero, is a
humanized monoclonal antibody against human interleukin-5 (IL-5).
Reslizumab binds specifically...
- are
rapidly reduced monoclonal antibody therapy – e.g.,
mepolizumab or
reslizumab against IL-5,
prevents eosinophilopoiesis, or
benralizumab against IL-5...
-
Interleukin 5 Antagonists: YM-90709 Antibodies:
Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:
Atexakin alfa Interleukin...
- interleukin-5 (IL-5) or its
receptor (IL-5R),
including mepolizumab,
reslizumab or benralizumab, in
addition to
standard care in
severe asthma is effective...
-
alleviate symptoms. Some
examples of
these drugs include mepolizumab,
reslizumab, and benralizumab.
Although eosinopenia has long been
recognized as a...
- COVID-19
Relatlimab mab
human LAG3
melanoma Remtolumab mab
human IL-17A, TNF
Reslizumab Cinqair mab
humanized IL-5 Y
inflammations of the airways, skin and gastrointestinal...
-
Altrakincept Pascolizumab IL-5-specific blockers:
Benralizumab Mepolizumab Reslizumab IL-13-specific blockers:
Lebrikizumab Tralokinumab Dual IL-4 and IL-13...
-
Interleukin 5 Antagonists: YM-90709 Antibodies:
Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:
Atexakin alfa Interleukin...
-
Interleukin 5 Antagonists: YM-90709 Antibodies:
Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:
Atexakin alfa Interleukin...
-
Interleukin 5 Antagonists: YM-90709 Antibodies:
Benralizumab Mepolizumab Reslizumab Antisense oligonucleotides: TPI ASM8 IL-6 Agonists:
Atexakin alfa Interleukin...
